跳至主要内容
临床试验/NL-OMON39451
NL-OMON39451已完成不适用

Effects of DDAVP (1-deamino-8-D arginine vasopressin) infusion on parameters of hemostasis in patients with liver cirrhosis - DDAVP in cirrhosis

niversitair Medisch Centrum Groningen0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Research group:
  • - Leeftijd > 18 yrs
  • - Non-cholestatic cirrhosis, with moderate to severe disease (Child B or C)
  • - Schedukled to visit the policlinic hepatology for routine check-up
  • - Informed consent
  • Control group (samples obtained in Erasmus MC Rotterdam for different research project)
  • - age>18 yrs
  • - hemophilia type A
  • - Informed consent

排除标准

  • - Age < 18 yrs
  • - Biliary cirrhosis
  • - Malignancies
  • - Renal failure requiring intervention with drugs or dialysis
  • - Active infection requiring intervention
  • - Recent (< 7 days before administration) transfusion of plasma or platelet concentrates
  • - Use of aspirin, other anti-platelet drugs, antifibrinolytic agents or vitamin K antagonists
  • - Angina Pectoris
  • - One of the following disorders of coagulation: hemophilia, Von Willebrand's disease, antithrombin deficiency, protein C deficiency or protein S deficiency

研究者

相似试验